F-Prime Capital Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • F-Prime Capital's estimated annual revenue is currently $7.5M per year.(i)
  • F-Prime Capital's estimated revenue per employee is $90,361

Employee Data

  • F-Prime Capital has 83 Employees.(i)
  • F-Prime Capital grew their employee count by 2% last year.

F-Prime Capital's People

NameTitleEmail/Phone
1
VP, Risk and ComplianceReveal Email/Phone
2
VP Human ResourcesReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
VP MarketingReveal Email/Phone
5
Director FinanceReveal Email/Phone
6
Partner & Chief Financial OfficerReveal Email/Phone
7
Director PlatformReveal Email/Phone
8
Director Industry NetworksReveal Email/Phone
9
Senior Director FinanceReveal Email/Phone
10
Senior Director FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$35M16N/AN/AN/A
#2
$3.5M120%N/AN/A
#3
$15M3N/AN/AN/A
#4
$3.5M33-21%N/AN/A
#5
$35M196%N/AN/A
#6
$15M22216%$2.2BN/A
#7
$15M413%$34MN/A
#8
$75M9723%N/AN/A
#9
$1.7M196%N/AN/A
#10
$300M12114%N/AN/A
Add Company

What Is F-Prime Capital?

Our roots are in one of America's great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.

keywords:N/A

N/A

Total Funding

83

Number of Employees

$7.5M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

F-Prime Capital News

2022-04-06 - Doceree Closes $11 Million Series A Funding Round Led by ...

F-Prime Capital and Alkemi Growth Capital also participated in the round. Doceree will use the funds to scale its global operations,...

2022-04-06 - Doceree Closes $11 Million Series A Funding Round Led by F-Prime Capital - Benzinga

F-Prime Capital, formerly Fidelity Biosciences and Devonshire Investors, is a global venture capital firm investing in life sciences,...

2022-04-06 - Health communications platform Doceree raises $11 mn in Series A funding round

F-Prime Capital and Alkemi Growth Capital also participated in the round. “It is critical for industry players like pharma companies and HCP-...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12M83-72%N/A
#2
$12.9M83-11%N/A
#3
$12M83N/AN/A
#4
$75M8311%$39.5M
#5
$12.9M8314%N/A